LAX.SH
METROPOLIS HEALTHCARE LTD·DIAGNOSTICS 63.67·Healthcare Services Companies
Price
556.95
+2.98%52W Range
Market Cap
₹11,547.12 Cr
Traded: ₹26.05 Cr (0.23%) 0.0x
Free Float: ₹568.12 Cr (4.59% of FF traded)
Volume · 60D trend
4.75 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +19.0% | +15.0% | +13.0% | -- | -- | Decelerating |
| Sales | +13.0% | +11.0% | +13.0% | -- | +24.0% | Accelerating |
| Profit | +11.0% | +1.0% | +11.0% | -- | +40.0% | Accelerating |
| Return | -- | -1.0% | +18.0% | +29.0% | -- | Accelerating |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 450 | 425 | 406 | 429 | 386 | 345 | 323 | 350 | 313 | 331 | 291 | 308 | 277 | 283 | 285 | 300 |
| Expenses | 339 | 317 | 311 | 321 | 296 | 283 | 251 | 260 | 235 | 251 | 226 | 234 | 214 | 212 | 215 | 221 |
| Operating Profit | 111 | 108 | 95 | 108 | 90 | 62 | 72 | 90 | 79 | 80 | 65 | 75 | 63 | 70 | 70 | 79 |
| OPM % | 25.0% | 25.0% | 23.0% | 25.0% | 23.0% | 18.0% | 22.0% | 26.0% | 25.0% | 24.0% | 22.0% | 24.0% | 23.0% | 25.0% | 25.0% | 26.0% |
| Other Income | 5 | 8 | 0 | 1 | 8 | 7 | 3 | 3 | 2 | 3 | 2 | 1 | 3 | 1 | 7 | 4 |
| Interest | 6 | 8 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 6 | 5 | 6 | 6 | 6 | 6 | 7 |
| Depreciation | 32 | 39 | 32 | 32 | 31 | 29 | 28 | 27 | 26 | 26 | 25 | 22 | 21 | 23 | 23 | 22 |
| Profit Before Tax | 78 | 70 | 57 | 71 | 61 | 36 | 42 | 61 | 51 | 51 | 37 | 48 | 39 | 42 | 48 | 55 |
| Tax % | 27.0% | 27.0% | 26.0% | 26.0% | 26.0% | 19.0% | 26.0% | 24.0% | 25.0% | 28.0% | 26.0% | 26.0% | 26.0% | 20.0% | 25.0% | 26.0% |
| Net Profit | 57 | 51 | 42 | 53 | 45 | 29 | 31 | 47 | 38 | 37 | 27 | 36 | 29 | 33 | 36 | 40 |
| Exceptional Items | -- | 0 | -9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- |
| EPS (Rs) | 2.7 | 2.5 | 2.0 | 2.5 | 2.2 | 1.4 | 1.5 | 2.3 | 1.9 | 1.8 | 1.3 | 1.7 | 1.4 | 1.6 | 7.0 | 7.9 |
| Sales Growth (YoY) | -- | 23.0% | 25.8% | 22.7% | 23.2% | 4.3% | 10.9% | 13.4% | 13.1% | 17.1% | 2.0% | 2.7% | -1.0% | -7.6% | -- | -- |
| Sales Growth (QoQ) | -- | 4.7% | -5.4% | 11.1% | 11.9% | 6.8% | -7.7% | 11.8% | -5.4% | 13.8% | -5.5% | 11.2% | -2.1% | -0.7% | -5.0% | -- |
| OP Growth (YoY) | 23.3% | 74.2% | 31.9% | 20.0% | 13.9% | -22.5% | 10.8% | 20.0% | 25.4% | 14.3% | -7.1% | -5.1% | -- | -- | -- | -- |
| OP Growth (QoQ) | 2.8% | 13.7% | -12.0% | 20.0% | 45.2% | -13.9% | -20.0% | 13.9% | -1.3% | 23.1% | -13.3% | 19.0% | -10.0% | 0.0% | -11.4% | -- |
| Profit Growth (YoY) | -- | 74.0% | 53.0% | 13.0% | 19.0% | -20.0% | 15.0% | 31.0% | 32.0% | 9.0% | -24.0% | -12.0% | -14.0% | -17.0% | -13.0% | -31.0% |
| EPS Growth (YoY) | -- | 74.5% | 30.7% | 11.9% | 17.3% | -20.8% | 15.0% | 31.2% | 31.2% | 9.2% | -81.0% | -78.0% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 23.0% | -21.3% | 17.1% | 53.9% | -7.8% | -32.6% | 22.7% | 3.9% | 33.8% | -23.1% | 22.7% | -13.5% | -76.7% | -11.3% | -- |
| OP Margin | -- | 25.4% | 23.4% | 25.2% | 23.3% | 18.0% | 22.3% | 25.7% | 25.2% | 24.2% | 22.3% | 24.4% | 22.7% | 24.7% | 24.6% | 26.3% |
| Net Margin | -- | 12.0% | 10.3% | 12.3% | 11.7% | 8.4% | 9.6% | 13.4% | 12.1% | 11.2% | 9.3% | 11.7% | 10.5% | 11.7% | 12.6% | 13.3% |
| Material Cost % | -- | 18.5% | 19.5% | 20.4% | 20.5% | 20.7% | 20.0% | 19.9% | 20.1% | 20.3% | 19.7% | 19.9% | 20.6% | 21.1% | 22.4% | 22.8% |
| Employee Cost % | -- | 22.5% | 23.2% | 22.2% | 23.9% | 23.8% | 25.2% | 22.4% | 22.9% | 21.6% | 23.9% | 22.6% | 23.5% | 22.8% | 22.6% | 20.5% |
| P/S | 6.75 | 7.36 | 7.26 | 6.65 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 57.24 | 63.74 | 16.87 | 62.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 7.63 | 8.01 | 7.94 | 6.89 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Disclosure under Regulation 30 of SEBI Listing Regulations
Schedule of Analyst / Institutional Investor Meeting
Scrutinizer''s Report for the 26th Annual General Meeting
Proceedings of the 26th Annual General Meeting of the Company
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Metz Advisory LLP & PACs
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Duru Shah Family Trust & PACs
Transcript of Q1 FY27 earnings conference call held on Wednesday, August 05, 2026
Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026
Outcome of Board Meeting
Annual Report for the financial year 2025-26
Business Responsibility and Sustainability Report for the financial year 2025-26
Notice of the 26th Annual General Meeting for the financial year 2025-26 to be held on August 18, 2026
Newspaper advertisement
Allotment of 36,900 equity shares under the Metropolis- Restrictive Stock Unit Plan, 2020
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026
Business update for Q1FY27
Closure of Trading Window
Annual Secretarial Compliance Report for the financial year ended March 31, 2026
Schedule of Analyst / Institutional Investor Meeting
Transcript of Q4 FY26 earnings conference call held on Thursday, May 14, 2026
General Update
Newspaper Publication
Link of audio recording of the earnings conference call held on May 14, 2026
Outcome of Board Meeting
Investor Presentation for the quarter ended March 31, 2026
Change in Management
Grant of Stock Benefits
Board approves 2nd Interim Dividend
Allotment of 4,200 equity shares under the Metropolis-Restrictive Stock Unit Plan, 2020
Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2026
Press Release
Schedule of Analyst / Institutional Investor Meeting
Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve a) Audited Standalone ....
The Company will participate in the Q4 FY26 earnings conference call (i.e. post earnings/quarterly call), organized by Ambit Capital on Thursday, May 14, 2026 at 09:00 a.m. (IST) to discuss ....
Schedule of Analyst / Institutional Investor Meeting
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026
Business update for Q4FY26
Closure of Trading Window
Allotment of Bonus Equity Shares
Schedule of Analyst / Institutional Investor Meeting
Schedule of Analyst / Institutional Investor Meeting
Intimation of Record Date for the purpose of Issuing Bonus Equity Shares
Scrutinizer''s Report
Outcome of Postal Ballot
Schedule of Analyst / Institutional Investor Meeting
Transcript of Q3 FY26 earnings conference call held on Thursday, February 05, 2026
Newspaper advertisement
Postal Ballot Notice for Issue of Bonus Shares
Link of audio recording of the earnings conference call held on February 05, 2026
Newspaper Publication
Annual Reports
7Credit Ratings
6Concalls
38Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Oct 2025
31 Oct 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Dec 2024
31 Dec 2024Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021Mar 2021
31 Mar 2021Nov 2020
30 Nov 2020Nov 2020
30 Nov 2020Aug 2020
31 Aug 2020Aug 2020
31 Aug 2020May 2020
31 May 2020Mar 2020
31 Mar 2020Feb 2020
29 Feb 2020Nov 2019
30 Nov 2019Sep 2019
30 Sept 2019Aug 2019
31 Aug 2019Aug 2019
31 Aug 2019Jul 2019
31 Jul 2019Jul 2019
31 Jul 2019May 2019
31 May 2019Held by ETFs
5 ETFs hold metropolis · sorted by weight
Held by Mutual Funds
43 schemes hold metropolis · sorted by weight